يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Brain Neoplasms: genetics"', وقت الاستعلام: 1.63s تنقيح النتائج
  1. 1

    المساهمون: Neurology, CCA - Cancer biology and immunology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

    المصدر: Acta Neuropathologica, 135(4), 601-615
    Acta Neuropathologica, 135, 4, pp. 601-615
    Acta Neuropathologica, 135(4), 601-615. Springer Verlag
    Acta Neuropathologica, 135, 601-615
    Acta Neuropathologica, 135(4), 601-615. SPRINGER
    Bady, P, Kurscheid, S, Delorenzi, M, Gorlia, T, van den Bent, M J, Hoang-Xuan, K, Vauléon, É, Gijtenbeek, A, Enting, R, Thiessen, B, Chinot, O, Dhermain, F, Brandes, A A, Reijneveld, J C, Marosi, C, Taphoorn, M J B, Wick, W, von Deimling, A, French, P, Stupp, R, Baumert, B G & Hegi, M E 2018, ' The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033 ', Acta Neuropathologica, vol. 135, no. 4, pp. 601-615 . https://doi.org/10.1007/s00401-018-1810-6Test
    Acta Neuropathologica, 135(4), 601-615. Springer, Cham
    Acta neuropathologica, vol. 135, no. 4, pp. 601-615
    Acta Neuropathologica, 135(4), 601-615. Springer-Verlag

    مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Epigenesis, Genetic, MISMATCH REPAIR, 0302 clinical medicine, Promoter Regions, Genetic, DNA Modification Methylases, DNA methylation, Brain Neoplasms, METHYLATION, TEMOZOLOMIDE, Glioma, Methylation, TUMORS, Isocitrate Dehydrogenase, Progression-Free Survival, 3. Good health, Treatment Outcome, Isocitrate dehydrogenase, CpG site, 030220 oncology & carcinogenesis, Female, DNA mismatch repair, Adult, Antineoplastic Agents, Alkylating/therapeutic use, Brain Neoplasms/genetics, Brain Neoplasms/pathology, Brain Neoplasms/therapy, CpG Islands, DNA, DNA Methylation/drug effects, DNA Methylation/radiation effects, DNA Modification Methylases/genetics, DNA Repair Enzymes/genetics, Discoidin Domain Receptors/genetics, Glioma/genetics, Glioma/pathology, Glioma/therapy, Humans, Isocitrate Dehydrogenase/genetics, Neoplasm Grading, Temozolomide/therapeutic use, Tumor Suppressor Proteins/genetics, DDR genes, Low-grade glioma, MGMT-STP27, Randomized trial, TMZ, SENSITIVITY, MGMT, medicine.drug, RADIOTHERAPY, EXPRESSION, medicine.medical_specialty, GLIOBLASTOMA, Other Research Donders Center for Medical Neuroscience [Radboudumc 0], Pathology and Forensic Medicine, 03 medical and health sciences, Cellular and Molecular Neuroscience, All institutes and research themes of the Radboud University Medical Center, Internal medicine, medicine, Progression-free survival, Antineoplastic Agents, Alkylating, Discoidin Domain Receptors, neoplasms, Temozolomide, business.industry, Tumor Suppressor Proteins, medicine.disease, DNA Repair Enzymes, 030104 developmental biology, CELLS, Neurology (clinical), business

    وصف الملف: application/pdf

  2. 2

    المساهمون: Pathology, CCA - Disease profiling, University of Zurich, Hegi, M E, Neurology, Radiation Oncology Groups, National Cancer Institute of Canada Clinical Trials Group, European Organisation for, Research, Treatment of Cancer Brain, Tumour

    المصدر: Acta Neuropathologica, 123(6), 841-852. Springer Verlag
    Acta Neuropathologica, 123, 841-52
    Acta Neuropathologica, 123(6), 841-852. Springer-Verlag
    Hegi, M E, Janzer, R C, Lambiv, W L, Gorlia, T, Kouwenhoven, M C, Hartmann, C, von Deimling, A, Martinet, D, Besuchet Schmutz, N, Diserens, A C, Hamou, M F, Bady, P, Weller, M, van den Bent, M J, Mason, W P, Mirimanoff, R O, Stupp, R, Mokhtari, K & Wesseling, P 2012, ' Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial ', Acta Neuropathologica, vol. 123, no. 6, pp. 841-852 . https://doi.org/10.1007/s00401-011-0938-4Test
    Acta Neuropathologica, 123, 6, pp. 841-52
    Acta neuropathologica
    Acta Neuropathologica, vol. 123, no. 6, pp. 841-852

    وصف الملف: Sammelmappe1.pdf - application/pdf; application/pdf